Skip to main content

datastreet.in

Dr Reddy’s pins hopes on semaglutide, but timely approvals hold the key

The company’s exports plan faces delays in approvals, with the pharmaceutical drugs directorate of Canada issuing it a notice of non-compliance in response to its application.

Source :- mint – markets Read More

Share it :

Leave a Reply

Your email address will not be published. Required fields are marked *